Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Q: What does CUSIP 05280R100 represent in this 13F holders report?

CUSIP 05280R100 is the security identifier for AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share used to aggregate holder disclosures.

Q: How many institutions held AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in Q4 2019?

54 institutional investors reported AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share for Q4 2019. Use the holders table for investor-level position and value details.

CUSIP: 05280R100

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Shares outstanding: 265,957,447
Total 13F shares: 13,423,917
Share change: -74,451
Total reported value: $177,195,289
Price per share: $13.20
Number of holders: 54
Value change: +$748,992
Number of buys: 26
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 05280R100:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q4 2019

As of 31 Dec 2019, Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,423,917 shares. The largest 10 holders included Capital World Investors, SCHRODER INVESTMENT MANAGEMENT GROUP, Polygon Management Ltd., PRICE T ROWE ASSOCIATES INC /MD/, JUPITER ASSET MANAGEMENT LTD, Alphabet Inc., MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, Capital International Investors, and Artal Group S.A.. This page lists 54 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.